Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways

PLoS Pathogens

Volumn 2, Issue 4, 2006, Pages 303-314

  Grant, Christian ^a   Oh, Unsong ^a   Fugo, Kazunori ^a   Takenouchi, Norihiro ^a   Griffith, Caitlin ^a   Yao, Karen ^a   Newhook, Timothy E ^a   Ratner, Lee ^b   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME REPRESSION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL LINE; NUCLEAR LOCALIZATION SIGNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN TARGETING; RETROVIRUS; SIGNAL TRANSDUCTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS INHIBITION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETICS; KIDNEY; METABOLISM; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

CD4-POSITIVE T-LYMPHOCYTES; CREB-BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, VIRAL; GENE TARGETING; HUMANS; JURKAT CELLS; KIDNEY; LEUKOCYTES, MONONUCLEAR; NF-KAPPA B; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 33646255425     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0020033     Document Type: Article

References (50)

1. Kamradt T, Mitchismon AA (2001) Tolerance and autoimmunity. N Engl J Med 344: 655-664.
2. Shevach EM (2002) CD4+CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2: 389-400.
3. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352.
4. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Fergusson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21.
5. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979.
6. Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S (2005) Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105: 735-741.
7. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
8. + T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115: 1361-1368.
9. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, et al. (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cell, which suppress HIV-specific CD4 T-cell responses in HIV-infected individuals. Blood 104: 3249-3256.
10. Tsunemi S, Iwasaki T, Imado T, Higasa S, Kakishita E, et al. (2005) Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. Aids 19: 879-886.
11. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
12. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
13. Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342.
14. Coffer PJ, Burgering BMT (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4: 889-899.
15. Bettelli E, Dastrange M, Oukka M (2005) Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 102: 5138-5143.
16. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276: 37672-37679.
17. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.
18. Ching YP, Chun ACS, Chin KT, Zhang ZQ, Jeang KT, et al. (2004) Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology 1: 18.
19. Lin L, Hron JD, Peng SL (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203-213.
20. Lin L, Spoor MS, Gerth AJ, Brody SL, Peng SL (2004) Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science 303: 1017-1020.
21. Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
22. Cron RQ, Bartz SR, Clausell A, Bort SJ, Klebanoff SJ, et al. (2000) NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin Immunol 94: 179-191.
23. Li C, Lai CF, Sigman DS, Gaynor RB (1991) Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A 88: 7739-7743.
24. Pernini G, Wagner S, Green MR (1995) Recognition of bZIP proteins by the human T-cell leukemia virus transactivator Tax. Nature 376: 602-605.
25. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, et al. (1995) Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature 376: 606-608.
26. Kwok RPS, Laurance ME, Lundblad JR, Goldman PS, Shih HM, et al. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380: 642-646.
27. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, et al. (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275: 11852-11857.
28. Li XH, Gaynor RB (2000) Mechanisms of NF-κB activation by the HTLV type 1 Tax protein. AIDS Res Hum Retroviruses 16: 1583-1590.
29. Suzuki T, Hirai H, Yoshida M (1994) Tax protein of HTLV-1 interacts with Rel homology domain of NF-κB p65 and c-Rel proteins bound to the NF-κB binding site and activates transcription. Oncogene 9: 3099-3105.
30. Kimata JT, Wong FH, Wang JJ, Ratner L (1994) Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204: 656-664.
31. Robek MD, Ratner L (1999) Immortilization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73: 4856-4865.
32. Collins ND, Newbound GC, Ratner L, Lairmore MD (1996) In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol 70: 7241-7246.
33. Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, et al. (2004) Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 cComplexes on CD4+ CD25+ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med 199: 1367-1377.
34. Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, et al. (2006) Reduced Foxp3 protein expression is associated with inflammatory disease in HTLV-I infection. J Infectious Disease. In press.
35. Mick JE, Colgin MA, Brauweiler A, Nyborg JK (2000) Analysis of CREB mutants in Tax compex formation and trans-activation. AIDS Res Hum Retroviruses 16: 1597-1601.
36. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK (2002) Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J Biol Chem 277: 49459-49465.
37. Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328: 175-178.
38. Gonzalez GA, Montminy MR (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680.
39. Dey A, Nebert DW, Ozato K (1991) The AP-1 site and the cAMP- and serum response elements of the c-fos gene are constitutively occupied in vivo. DNA Cell Biol 10: 537-544.
40. Nichols M, Weih F, Schmid W, DeVack C, Kowenz-Leutz E, et al. (1992) Phosphorylation of CREB affects its binding to high and low affinity sites: Implications for cAMP induced gene expression. EMBO J 11: 3337-3346.
41. Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, et al. (1993) Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol 13: 4852-4859.
42. Chang X, Gao JX, Jiang Q, Wen J, Seifers N, et al. (2005) The Scurfy mutation of FoxpP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 202: 1141-1151.
43. Ochs HD, Ziegler SF, Torgerson TR (2005) Foxp3 acts as a rheostat of the immune response. Immunol Rev 203: 156-164.
44. Li S, Weidenfeld J, Morrisey EE (2004) Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24: 809-822.
45. Apoil PA, Puissant B, Roubinet F, Abbal M, Massip P, et al. (2005) Foxp3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 39: 381-385.
46. Kinter AL, Hennessey M, Bell A, Kern A, Lin Y, et al. (2004) CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200: 331-343.
47. Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, et al. (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-I-associated myelopathy (HAM/TSP). Blood 99: 88-94.
48. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
49. Osame M (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W, editor. Human retrovirology HTLV. New York: Raven Press. pp. 191-197.
50. Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, et al. (2001) Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 183: 197-205.